Back to Journals » Research Reports in Clinical Cardiology » Volume 5

Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking

Authors Maury P, Rollin A, Galinier M, Juillière Y

Received 4 February 2014

Accepted for publication 4 March 2014

Published 7 May 2014 Volume 2014:5 Pages 93—101


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 6

Philippe Maury,1 Anne Rollin,1 Michel Galinier,1 Yves Juillière2

1University Hospital Rangueil, Toulouse, France; 2Institut Lorrain du Coeur de des Vaisseaux Louis Mathieu, Nancy, France

Abstract: Although digitalis has been used since the last century, it seems to be in the process of being progressively abandoned. However, digoxin has demonstrated a large positive benefit in terms of reduction of morbidity in heart failure patients with sinus rhythm, while the sometimes-observed increase in mortality is dramatically reduced with low serum concentrations. Digoxin, which is the only digitalis currently available, remains one of three drugs used for rate control in atrial fibrillation. Even if digoxin alone is insufficient to provide rate control during exertion in most patients, the optimal cardiac rate both at rest and at exertion is still undetermined, as is the importance of achieving sufficient rate control in asymptomatic patients. Because of its low cost and the accumulated knowledge and expertise about prescription, digoxin probably will remain an undisputed medication for rate control for atrial fibrillation, especially for heart failure patients.

Keywords: digitalis, heart failure, atrial fibrillation, heart rate

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]